How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q2 2023?

69 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 41,007,449
Share change: +2,198,569
Total reported value: $134,502,613
Put/Call ratio: 2.1%
Price per share: $3.28
Number of holders: 69
Value change: +$8,714,482
Number of buys: 42
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Rubric Capital Management LP	13F	Company	5.2%	7,001,124	$18,062,900	—	31 Mar 2023	13F
BVF INC/IL	13F	Company	5.1%	6,851,051	$17,675,712	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	4.5%	6,117,400	$15,782,892	—	31 Mar 2023	13F
Madison Avenue Partners, LP	13F	Company	2.3%	3,104,603	$8,009,876	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.9%	2,610,602	$6,735,354	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	1.9%	2,500,000	$6,450,000	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.3%	1,780,873	$4,592,000	—	31 Mar 2023	13F
TLS Advisors LLC	13F	Company	1%	1,380,346	$3,516,000	—	31 Mar 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.93%	1,257,337	$3,243,929	—	31 Mar 2023	13F
CHI Advisors LLC	13F	Company	0.64%	864,822	$2,231,241	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.62%	827,580	$2,135,156	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.54%	725,887	$1,872,789	—	31 Mar 2023	13F
Amit Rakhit PoA	3/4/5	President and CMO	— mixed-class rows	817,806 mixed-class rows	$1,562,669	—	14 Jul 2021	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	499,635	$1,289,058	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.32%	430,661	$1,111,106	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.25%	339,160	$875,033	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.2%	272,916	$704,000	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	0.2%	267,459	$690,042	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.14%	191,733	$494,671	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	163,766	$422,516	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.11%	142,838	$368,522	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	120,600	$311,000	—	31 Mar 2023	13F
Tejara Capital Ltd	13F	Company	0.09%	118,791	$306,481	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.08%	108,652	$280,322	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.08%	108,615	$280,227	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.07%	91,400	$235,812	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.06%	83,014	$214,176	—	31 Mar 2023	13F
Boston Partners	13F	Company	0.06%	77,003	$198,670	—	31 Mar 2023	13F
DCF Advisers, LLC	13F	Company	0.05%	68,264	$176,120	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.05%	63,741	$164,452	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	57,837	$149,220	—	31 Mar 2023	13F
BANK OF NOVA SCOTIA	13F	Company	0.03%	43,356	$111,858	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	35,638	$91,946	—	31 Mar 2023	13F
Y-Intercept (Hong Kong) Ltd	13F	Company	0.03%	35,116	$90,599	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.02%	32,862	$84,784	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.02%	30,858	$79,614	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.02%	27,500	$71,000	—	31 Mar 2023	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.02%	26,000	$67,080	—	31 Mar 2023	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.02%	24,328	$62,766	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.02%	24,056	$62,064	—	31 Mar 2023	13F
CANNELL CAPITAL LLC	13F	Company	0.02%	22,620	$58,360	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	18,069	$46,618	—	31 Mar 2023	13F
Virtu Financial LLC	13F	Company	0.01%	17,892	$46,000	—	31 Mar 2023	13F
Newman Dignan & Sheerar, Inc.	13F	Company	0.01%	15,522	$40,047	—	31 Mar 2023	13F
Mariner, LLC	13F	Company	0.01%	13,500	$35,000	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	13,112	$33,829	—	31 Mar 2023	13F
BAILARD, INC.	13F	Company	0.01%	12,600	$32,508	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.01%	11,271	$29,079	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	11,174	$28,829	—	31 Mar 2023	13F
Middle East Fze Point72	13F	Individual	0%	5,993	$15,462	—	31 Mar 2023	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2023

As of 30 Jun 2023, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,007,449 shares. The largest 10 holders included BVF INC/IL, EcoR1 Capital, LLC, Rubric Capital Management LP, BlackRock Inc., Madison Avenue Partners, LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, TLS Advisors LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.